Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 1, 2007, Pages 57-67

  Carrara, R C V ^a   Orellana, M D ^a   Fontes, A M ^a   Palma, P V B ^a   Kashima, S ^a   Mendes, M R ^a   Coutinho, M A ^a   Voltarelli, J C ^a   Covas, D T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Bcr abl gene; Chimerism; Chronic myeloid leukemia; Mesenchymal stem cells

Indexed keywords

BCR ABL PROTEIN; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ADIPOCYTE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL SEPARATION; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTAMINATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DONOR; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPE 46,XX; KIDNEY FAILURE; LIVER FAILURE; MALE; MESENCHYMAL STEM CELL; MUCOSA INFLAMMATION; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; X CHROMOSOME; Y CHROMOSOME;

EID: 33846278744     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000100008     Document Type: Article

References (28)

1. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 1995; 85: 3636-3645.
2. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
3. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001; 7: 259-264.
4. Minguell JJ, Erices A, Conget P. Mesenchymall stem cells. Exp Biol Med 2001; 226: 507-520.
5. Silva WA Jr, Coves DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003; 21: 661-669.
6. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497 (Abstract).
7. Kabarowski JH, Witte ON. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells 2000; 18: 399-408.
8. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000, 96. 3343-3356.
9. Gunsilius E, Duba HC, Petzer AL, Kehler CM, Grunewald K, Stockhammer G, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000; 355: 1688-1691.
10. Fang B, Zheng C, Liao L, Han Q, Sun Z, Jiang X, et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 2005; 105: 2733-2740.
11. Awaya N, Rupert K, Bryant E, Torok-Storb B. Failure of adult marrow-dedved stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 2002; 30: 937-942.
12. Stute N, Fehse B, Schroder J, Arps S, Adamietz P, Held KR, et al. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant. J Hematother Stem Cell Res 2002; 11: 977-984.
13. Cilloni D, Carlo-Stella C, Falzetti F, Sammarelli G, Regazzi E, Colla S, et al. Limited engraftment capacity of bone marrow-derived mesenchymal calls following T-cell-depleted hematopoietic stem cell transplantation. Blood 2000; 96: 3637-3643.
14. Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sanchez-Abarca LI, Sanchez-Guijo FM, et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem call transplantation. Haematologica 2004; 89: 1421-1427.
15. Rieger K, Marinets O, Fietz T, Korper S, Sommer D, Mucke C, et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 2005; 33: 605-611.
16. Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controiled trial. Br J Haematol 1989; 72: 567-572.
17. Covas DT, Siufi JL, Silva AR, Orellana MD. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 2003; 36: 1179-1183.
18. Courtinho V, Bottura C. Método direto para o estudo dos cromossomos humanos. Rev Paul Med 1968; 72: 9-13.
19. Moorhead PS, Nowell PC, Mailman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell Res 1960; 20: 613-616.
20. Mitelman F. ISCN 1995. An international system for human cytogenetic nomenclature. Switzerland: S. Karger AG/Cytogenetics and Cell Genetics; 1995.
21. Zhao Z, Tang X, You Y, Li W, Liu F, Zou P. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hematopoiesis function in patients with chronic myeloid leukemia. Leuk Res 20006; 300: 993-1003.
22. Hayakawa J, Migita M, Ueda T, Shimada T, Fukunaga Y. Generation of a chimeric mouse reconstituted with green fluorescent protein-positive bone marrow cells: a useful model for studying the behavior of bone marrow cells in regeneration in vivo. Int J Hematol 2003; 77: 456-462.
23. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999-3001.
24. Chapel A, Bertho JM, Bensidhourn M, Fouillard L, Young RG, Frick J, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003; 5: 1028-1038.
25. Mahmud N, Pang W, Cobbs C, Alur P, Borneman J, Dodds R, et al. Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymall stem cell engraftment in a nonhuman primate model. Exp Hematol 2004; 32: 494-501.
26. Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, et al. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature 1982; 298: 280-283.
27. Villaron EM, Perez-Simon JA, San Miguel JF, del Canizo C. Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation. Exp Hematol 2006; 34: 7.
28. Poloni A, Leoni P, Buscemi L, Balducci F, Pasquini R, Masia MC, et al. Engraftment capacity of mesenchymall cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 2006; 20: 329-335.